Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

3.8%

5 terminated/withdrawn out of 130 trials

Success Rate

92.1%

+5.5% vs industry average

Late-Stage Pipeline

18%

24 trials in Phase 3/4

Results Transparency

2%

1 of 58 completed trials have results

Key Signals

21 recruiting1 with results

Enrollment Performance

Analytics

N/A
45(56.3%)
Phase 4
14(17.5%)
Phase 3
10(12.5%)
Phase 2
6(7.5%)
Phase 1
5(6.3%)
80Total
N/A(45)
Phase 4(14)
Phase 3(10)
Phase 2(6)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (130)

Showing 20 of 130 trials
NCT07847216Not Yet Recruiting

Multicenter Prospective Study Protocol for Validating Surgical Quality Standards in D3 Lymphadenectomy for Oncological Right Hemicolectomy

Role: collaborator

NCT07699549Completed

Long-term Atogepant in Real-world Practice

Role: collaborator

NCT06052436Phase 1Recruiting

Cell Therapy With Treg Cells Obtained From Thymic Tissue (thyTreg) to Control the Immune Hyperactivation Associated With COVID-19 and/or Acute Respiratory Distress Syndrome (THYTECH2)

Role: lead

NCT06778564Phase 3Recruiting

Stratification and Treatment in Early Psychosis Study - ENHANCE

Role: collaborator

NCT06300515Not ApplicableRecruiting

Exercise and Health Counseling in Pediatric Hematopoietic Stem Cell Transplantation

Role: collaborator

NCT05781243Phase 4Completed

Normal Saline Versus Lactated Ringer's Solution for Acute Pancreatitis Resuscitation

Role: collaborator

NCT07658755Recruiting

Automated Passive Case-Finding for Advanced Liver Fibrosis in MASLD: The LiverSeek Programme

Role: lead

NCT07655115Phase 3Recruiting

Single Dose Double-blind, Placebo-controlled Cross-over (SDDBPCCO) Shiftability Study, Will be Followed by a 10-week Open-label Study With Arbaclofen (4 Weeks of Titration and Then 6 Weeks of Active/Stable Treatment). The Effects of Arbaclofen on Target EEG and ERG Metrics Will be Associated With th

Role: lead

NCT07537517Recruiting

Evaluation of the BMPR2-Activin Signaling Pathway in Group II Pulmonary Hypertension.

Role: lead

NCT07484009Not ApplicableRecruiting

ReDS-guided Decongestion Strategy in Patients Hospitalized for Heart Failure

Role: collaborator

NCT07467512Not ApplicableNot Yet Recruiting

Exercise for an Aging Liver (EXALIVER)

Role: collaborator

NCT07419321Recruiting

Social Isolation and Aging in Schizophrenia

Role: collaborator

NCT07422090Recruiting

Preventing Suicide With Digital Phenotyping and Pharmacogenetics-Based Interventions

Role: collaborator

NCT05772182Completed

Non-invasive Tool to Assess Electrophysiological Mechanisms in Cardiac Arrhythmias

Role: collaborator

NCT07326124Phase 3Not Yet Recruiting

Stratification and Treatment in Early Psychosis Study -ASSIST

Role: collaborator

NCT05448846Not ApplicableActive Not Recruiting

Exercise Program for Colorectal Older Patients

Role: lead

NCT06963268Phase 3Recruiting

Validation of the Sentinel Lymph Node Technique in Early-stage Ovarian Cancer (SENTOV II)

Role: collaborator

NCT07255378Recruiting

Use of Vassopresin in Septic Shock Prospective Multicenter Observational Study With Medication

Role: collaborator

NCT07128030Not ApplicableRecruiting

Moderate-Intensity Exercise and Pain Sensitization in Breast Cancer Survivors: A Case-Based Study

Role: collaborator

NCT07240038Recruiting

Reduction of the Incidence of NAV in Neonatal Units (INBERNAV-Neo)

Role: collaborator